PM Case 2: ALTERRA TPVR
Emory Percutaneous Intervention Course
93 videos
The Emory Percutaneous Intervention Course is the longest running annual interventional cardiology event in the world. Based on the teachings of founder Dr. Andreas Gruentzig, EPIC has provided...
Read More
The Emory Percutaneous Intervention Course is the longest running annual interventional cardiology event in the world. Based on the teachings of founder Dr. Andreas Gruentzig, EPIC has provided training for thousands of interventional cardiologists from the United States and abroad since 1981.
The meeting’s mission is to engage interventional cardiologists and cardiac surgeons specializing in coronary and structural heart disease to further enhance the care of their patients, mentor and train future generations of cardiovascular specialists, and lead front-line clinical research in the field.
Speakers
Dennis Kim, MD, PhD is a board-certified interventional cardiologist for both pediatric and adult congenital heart...
Dennis Kim, MD, PhD is a board-certified interventional cardiologist for both pediatric and adult congenital heart patients, and serves as the Director of the Pediatric Cardiac Catheterization Labs at the Children’s Healthcare of Atlanta Heart Center. In addition to providing patient care, Dr. Kim holds an academic appointment, serving as a Professor of Pediatrics at the Emory University School of Medicine to train the next generation of pediatric cardiologists. Dr. Kim received his medical education at the University of Texas Medical Branch at Galveston and completed his residency in pediatrics at the University of Michigan in Ann Arbor, MI. Dr. Kim completed pediatric cardiology and pediatric interventional cardiology fellowships at the University of Michigan Congenital Heart Center, receiving focused training in advanced cardiac therapies and catheterization techniques. In his role as Director of the Pediatric Cardiac Catheterization Labs, Dr. Kim ensures that the Children’s Heart Center provides the full spectrum of diagnostic and interventional capabilities to deliver the best possible heart care to patients. He is skilled in interventional procedures and minimally invasive treatments for congenital heart disease, such as transcatheter valve replacement and septal defect repair, and is involved in a variety of clinical trials for new transcatheter device therapies.
Dr. Rogers is an interventional cardiologist and scientific lead for the MedStar Heart & Vascular Institute...
Dr. Rogers is an interventional cardiologist and scientific lead for the MedStar Heart & Vascular Institute Structural Heart Disease program. He has a special interest in all aspects of minimally invasive treatment of structural heart disease, including Transcatheter Aortic Valve Replacement (TAVR), Transcaval access, Transcatheter Electrosurgery (LAMPOON and BASILICA techniques), para-valvular leak closure, percutaneous treatment of mitral valve regurgitation including Mitraclip and Transcatheter Mitral Valve Replacement (TMVR), LAA occluder, percutaneous pulmonary and tricuspid valve interventions, and cerebral protection devices for TAVR.
Vasilis Babaliaros, MD is Professor of Medicine and Surgery at Emory University School of Medicine, and Co-Director...
Vasilis Babaliaros, MD is Professor of Medicine and Surgery at Emory University School of Medicine, and Co-Director of the Emory Structural Heart and Valve Center. He received his bachelor of science in biomedical engineering, summa cum laude, from Duke University, and his medical degree, magna cum laude, from Emory University. He also completed his training in Internal Medicine, Cardiology and Interventional Cardiology at Emory University. He received advanced training in valvular intervention under the direction of Alain Cribier at the University of Rouen, France before returning to Emory to join the faculty. His research interests include percutaneous cardiac valve repair and replacement as well as treatment of structural and congenital heart disease.
Start a conversation